GENOCEA BIOSCIENCES INC - COM NEW (GNCA)

CUSIP: 372427401

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM NEW
Total 13F shares
6,499,501
Share change
-903,896
Total reported value
$18,845,000
Put/Call ratio
0%
Price per share
$2.90
Number of holders
29
Value change
-$3,570,812
Number of buys
15
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q3 2019

As of 30 Sep 2019, GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,499,501 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., DAFNA Capital Management LLC, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., FNY Investment Advisers, LLC, Polaris Venture Management Co. V, L.L.C., RENAISSANCE TECHNOLOGIES LLC, and Endurant Capital Management LP. This page lists 29 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.